Literature DB >> 24309369

Chemotherapy for small-cell lung cancer.

Gregory P Kalemkerian1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24309369     DOI： 10.1016/S1470-2045(13)70555-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  6 in total

1.  Isoaspartylation appears to trigger small cell lung cancer-associated autoimmunity against neuronal protein ELAVL4.

Authors:  Mario A Pulido; Meleeneh Kazarian DerHartunian; Zhenxia Qin; Eric M Chung; Diane S Kang; Andrew W Woodham; Jeffrey A Tsou; Rinse Klooster; Omid Akbari; Lina Wang; W Martin Kast; Stephen V Liu; Jan J G M Verschuuren; Dana W Aswad; Ite A Laird-Offringa
Journal:  J Neuroimmunol       Date:  2016-09-03       Impact factor: 3.478

2.  A noteworthy treatment of metastatic small-cell lung cancer with afatinib, followed by subsequent development of rare metastatic lesions in the ascending and sigmoid colon.

Authors:  Shih-Chuan Hsiao; Yi-Hsien Chen; Ching-Chu Lo; Ching-I Lin
Journal:  Cancer Rep (Hoboken)       Date:  2020-03-12

3.  Low-Dose Radiation Induces Cell Proliferation in Human Embryonic Lung Fibroblasts but not in Lung Cancer Cells: Importance of ERK1/2 and AKT Signaling Pathways.

Authors:  Xinyue Liang; Junlian Gu; Dehai Yu; Guanjun Wang; Lei Zhou; Xiaoying Zhang; Yuguang Zhao; Xiao Chen; Shirong Zheng; Qiang Liu; Lu Cai; Jiuwei Cui; Wei Li
Journal:  Dose Response       Date:  2016-01-06       Impact factor: 2.658

Review 4.  Single-Cell Analysis of Circulating Tumor Cells: Why Heterogeneity Matters.

Authors:  Su Bin Lim; Chwee Teck Lim; Wan-Teck Lim
Journal:  Cancers (Basel)       Date:  2019-10-19       Impact factor: 6.639

5.  Increased Expression of TGFβR2 Is Associated with the Clinical Outcome of Non-Small Cell Lung Cancer Patients Treated with Chemotherapy.

Authors:  Yang Han; Chengyou Jia; Xianling Cong; Fei Yu; Haidong Cai; Suyun Fang; Li Cai; Huiqiong Yang; Yu Sun; Dan Li; Jin Liu; Ruting Xie; Xueyu Yuan; Xiaoming Zhong; Ming Li; Qing Wei; Zhongwei Lv; Da Fu; Yushui Ma
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

6.  Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer.

Authors:  Taofeek K Owonikoko; Guojing Zhang; Hyun S Kim; Renea M Stinson; Rabih Bechara; Chao Zhang; Zhengjia Chen; Nabil F Saba; Suchita Pakkala; Rathi Pillai; Xingming Deng; Shi-Yong Sun; Michael R Rossi; Gabriel L Sica; Suresh S Ramalingam; Fadlo R Khuri
Journal:  J Transl Med       Date:  2016-05-03       Impact factor: 5.531
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.